PierianDx Partners with the Belgian Society of Medical Oncology (BSMO) to Evaluate Potential of Comprehensive Genomic Profiling in Late-Stage Cancer Real-World Setting Across Belgium
PierianDx, the global leader in clinical genomics knowledge, today announced a partnership with the Belgian Society of Medical Oncology (BSMO) to study the impact of comprehensive genomic profiling (CGP) on clinical outcomes of late-stage cancer patients. As part of the study, nine sites across Belgium will use the PierianDx interpretation and reporting solution, Clinical Genomics Workspace™ (CGW), to help determine the best therapeutic options for treatment.
Current approaches to precision medicine testing often mean that tests are outsourced to large international organizations or that they are run by independent regional labs, neither of which result in standardized clinical care systems or improved collective knowledge. In response to these challenges, the BSMO has established the BALLETT (Belgian Approach for Local Laboratory Extensive Tumor Testing) study to evaluate the impact of CGP.
CGP uses next-generation sequencing (NGS) to analyze hundreds of genes and biomarkers in tissue samples from biopsies or blood and detect those that are clinically relevant in driving cancer growth. Illumina will provide its CGP panel for tissue samples, TruSight™ Oncology 500 (TSO500), and NovaSeq™ 6000 and NextSeq™ sequencing platforms for the study. Clinical interpretation of the sequencing data will be carried out using the PierianDx Clinical Genomics Workspace™ (CGW) solution.
CGW provides a streamlined, standardized analysis platform in which EU drug approvals and guidelines are matched to complex genetic variants detected in patient tumor DNA and RNA, all within a GDPR-compliant environment. Using the platform, the nine participating Belgian laboratories can collaboratively review variant pathogenicity and clinical impact for their local samples while also benefiting from the knowledge of other clinical laboratory CGW users from around the world. At the same time, the nine Belgian laboratories will provide this standardized testing and analysis close to the patient’s home, where they receive cancer care, accelerating treatment initiation. As this study will also monitor the patient outcomes during and following treatment, a true indication of those longer-term clinical benefits will be derived.
Dr. Brigitte Maes of the Jessa Hospital in Belgium, Coordinator of BALLETT study said, “As part of Belgium’s broad approach to advancing precision medicine the study will generate valuable insights into the value of CGP versus currently reimbursed sequencing approaches. For example, in addition to genetic mutations that drive cancer formation, CGP will also identify cancers driven by the TMB biomarker which can guide patients towards immunotherapy treatments. This means that the study will give access to additional treatments which may not have been considered through more traditional diagnostic testing.”
Dr. Rakesh Nagarajan, Founder of PierianDx states, “We are ecstatic to be part of this groundbreaking study. The CGW platform is in use by over 25 countries to share knowledge and facilitate better treatments and patient outcomes, and now the clinicians involved in this study will benefit from this collective knowledge while incorporating European-specific data sources, which are curated and maintained by PierianDx.” He adds, “Not only will this study measure the impacts of CGP but it will provide a justification, framework, and a blueprint for other clinical laboratories around the world that wish to implement similar initiatives.”
About PierianDx
Founded in 2014 out of Washington University in St. Louis, PierianDx is focused on advancing cancer diagnostics and making targeted therapeutics more accessible to healthcare systems, laboratories, and patients worldwide. Its industry-leading clinical genomics technologies, CAP and CLIA accredited laboratory, IVD-ready knowledgebase and reporting solution, and expertise deliver the most integrated, trusted, and collaborative approach across the clinical care spectrum. From genomic sequencing and biomedical informatics in the laboratory to reporting and decision support at the patient’s bedside, PierianDx drives the adoption of genomics in clinical care and accelerates the fight against somatic cancer and hereditary germline diseases. For more information visit www.pieriandx.com.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20210204005303/en/
Contact information
Lisa Owen
info@pieriandx.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Sutherland and Celona Launch AI-Enabled Private 5G and Autonomous Network Solution for Enterprises and Service Providers Globally12.11.2025 15:00:00 EET | Press release
In a move set to redefine how enterprises and service providers manage mission-critical connectivity, Sutherland, a global leader in business and digital transformation, today announced the launch of an AI-enabled Private 5G and Autonomous Network solution in collaboration with Celona, the Silicon Valley innovator that pioneered the 5G LAN architecture. This end-to-end offering brings together Sutherland’s Agentic Service Management Orchestration (SMO) platform and suite of AI-enabled xApps and rApps with Celona’s next-generation private 5G infrastructure. The result is a self-managing, intent-based network that dramatically reduces human intervention while increasing performance, resilience, and sustainability across enterprise and telecom environments. “Enterprises no longer want to manage networks — they want networks that manage themselves,” said Sriram Panchapakesan, Chief Executive Officer of Communications, Media & Entertainment, Sutherland. “By combining autonomy with intellige
Armis Expands Technology Partner Ecosystem to Help Global Organizations Fortify Cyber Defenses12.11.2025 15:00:00 EET | Press release
Armis, the cyber exposure management & security company, today announced 11 new global technology integration partners. These integrations enhance joint customers’ existing technology stacks, enabling them to streamline security operations and reduce their cyber risk exposure. “The era of fragmented security is over – organizations demand best-in-class solutions that work seamlessly together to solve today's most complex cybersecurity challenges,” said Nadir Izrael, CTO and Co-Founder at Armis. “By partnering with other industry leaders, we are not just integrating tools; we are delivering a unified security ecosystem that reduces complexity and empowers joint customers to optimize their technology investments. This supports businesses in staying ahead of threats and protecting their most critical assets with confidence.” New Armis global technology integration partners include BlastWave, Cato Networks, Checkmarx, CyCognito, Elastic, Onyxia Cyber, Profitap, TeamDynamix, Tines, Sygnia,
Vasion Welcomes Cindy White Cybersecurity Expert and Former Microsoft Marketing Leader as Chief Marketing Officer12.11.2025 15:00:00 EET | Press release
Vasion, a leader in serverless printing and AI-enabled automation, today announced the appointment of Cindy White as Chief Marketing Officer, effective October 2025. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251112275154/en/ Vasion CMO Cindy White brings more than 25 years of experience leading high performance marketing teams at global technology companies. As organizations accelerate their transition to the cloud, Vasion is redefining what’s possible in the print and process automation landscape. Vasion enables tens of thousands of global customers to start with intelligent print and move to print intelligence, removing friction, cost, and risk from critical print environments, empowering them to move faster with secure, cloud-native, AI-based solutions. “Cindy’s global expertise and proven ability to scale marketing organizations across both direct and partner-driven go-to-markets will be instrumental as Vasion conti
Stealth Third Rock Ventures Backed Company Selects Parse Biosciences GigaLab to Build Largest TCR Atlas for Common Autoimmune Disease12.11.2025 15:00:00 EET | Press release
Third Rock Ventures and Parse Biosciences today announced a strategic collaboration to create an unprecedented atlas of 5 million T cell receptors (TCRs) using Parse Biosciences’ GigaLab platform. The project is led by a stealth Third Rock Ventures portfolio company that is developing precision medicines for autoimmune disease. The first-of-its-kind study will generate the world’s largest TCR dataset focused on T-cell mediated autoimmune disease, offering an essential resource to decode disease-driving immune signatures and reveal novel therapeutic targets. The new company will leverage the insights provided by mapping the genetic diversity of TCRs at this massive scale to speed the development of novel precision medicines for underserved patients with limited options today. “This effort positions us to deliver the most comprehensive TCR Atlas for T-cell mediated disease ever assembled,” said Dr. Hugo Hilton, Principal at Third Rock Ventures, who is guiding discovery and development fo
Cooler Master Expands the MasterFrame Series with the Compact and Modular MasterFrame 400 Mesh12.11.2025 14:07:00 EET | Press release
Cooler Master, a global leader in PC components and tech lifestyle solutions, today announced the MasterFrame 400 Mesh, a compact PC case that brings the signature MasterFrame design language to a more accessible, desk-friendly format. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251112507322/en/ MasterFrame 400 Mesh shown with V4 3DHP air cooler. The MasterFrame 400 Mesh delivers FreeForm 2.0 modularity in a simplified build experience. It offers dual orientation for vertical or horizontal setups, repositionable brackets, and mesh-optimized airflow so builders can tailor layout and thermals with confidence. The result is a compact footprint that still supports serious hardware. The case is engineered for Micro-ATX and Mini-ITX systems and supports high-performance components without compromise. Builders can install GPUs up to 390 mm and air coolers up to 190 mm. Cooling headroom is extensive, with support for up to nine f
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom